<SEC-DOCUMENT>0001072613-18-000099-index.html : 20180209 <SEC-HEADER>0001072613-18-000099.hdr.sgml : 20180209 <ACCEPTANCE-DATETIME>20180209120313 ACCESSION NUMBER: 0001072613-18-000099 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180209 DATE AS OF CHANGE: 20180209 GROUP MEMBERS: COREY GOODMAN GROUP MEMBERS: ROBERT ADELMAN GROUP MEMBERS: VENBIO GLOBAL STRATEGIC GP II, L.P. GROUP MEMBERS: VENBIO GLOBAL STRATEGIC GP II, LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89113 FILM NUMBER: 18589864 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: venBio Global Strategic Fund II L.P. CENTRAL INDEX KEY: 0001634632 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-522-0100 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G/A <SEQUENCE>1 <FILENAME>sch13g_18163.htm <DESCRIPTION>VENBIO GLOBAL STRATEGIC FUND II, L.P. / NABRIVA THERAPEUTICS AG - SCHEDULE 13GA (AMEND. #2) <TEXT> Document 1 - file: sch13g_18163.htm
</DOCUMENT> </SEC-DOCUMENT>